914 results on '"Al‐kuraishy, Hayder M."'
Search Results
2. A Mutual Nexus Between Epilepsy and α-Synuclein: A Puzzle Pathway
3. Therapeutic Potential Effect of Glycogen Synthase Kinase 3 Beta (GSK-3β) Inhibitors in Parkinson Disease: Exploring an Overlooked Avenue
4. Hypoglycemia and Alzheimer Disease Risk: The Possible Role of Dasiglucagon
5. Increased thyroid stimulating hormone (TSH) as a possible risk factor for atherosclerosis in subclinical hypothyroidism
6. The anti-inflammatory properties of vinpocetine mediates its therapeutic potential in management of atherosclerosis
7. Role of GABA pathway in motor and non-motor symptoms in Parkinson's disease: a bidirectional circuit
8. Editorial Expression of Concern: The Possible Role of Brain-derived Neurotrophic Factor in Epilepsy
9. Possible role of LCZ696 in atherosclerosis: new inroads and perspective
10. The therapeutic value of Myrtus communis L.: an updated review
11. Therapeutic potential of Lawsonia inermis Linn: a comprehensive overview
12. The potential link between acromegaly and risk of acute ischemic stroke in patients with pituitary adenoma: a new perspective
13. Potential pharmaceutical applications and molecular docking study for green fabricated ZnO nanoparticles mediated Raphanus sativus: In vitro and in vivo study
14. Blunted Melatonin Circadian Rhythm in Parkinson’s Disease: Express Bewilderment
15. The Molecular Pathway of p75 Neurotrophin Receptor (p75NTR) in Parkinson’s Disease: The Way of New Inroads
16. COVID-19 and β-thalassemia: in lieu of evidence and vague nexus
17. The potential therapeutic effect of phosphodiesterase 5 inhibitors in the acute ischemic stroke (AIS)
18. The effects of cholesterol and statins on Parkinson’s neuropathology: a narrative review
19. Irisin/PGC-1α/FNDC5 pathway in Parkinson’s disease: truth under the throes
20. The probable role of tissue plasminogen activator/neuroserpin axis in Alzheimer’s disease: a new perspective
21. Metformin role in Parkinson’s disease: a double-sword effect
22. The Possible Role of Brain-derived Neurotrophic Factor in Epilepsy
23. SARS-CoV-2 infection and dysregulation of nuclear factor erythroid-2-related factor 2 (Nrf2) pathway
24. A phytochemical and pharmacological review of Ricinus communis L.
25. In silico pharmacokinetic and therapeutic evaluation of Musa acuminata peels against aluminium chloride-induced hepatotoxicity in adult BALB/c mice
26. Statins for vascular dementia: A hype or hope
27. The potential therapeutic role of berberine in treating epilepsy focusing on temporal lobe epilepsy: State of art and ongoing perspective
28. Organ-specific renal tissue damage manifested by single-walled carbon-nanotubes and single-walled carbon-nanotubes-silver-titania nanocomposite: Cellular toxicity at high doses
29. The possible role of cerebrolysin in the management of vascular dementia: Leveraging concepts
30. The possible therapeutic role of advanced glycation end-product inhibitors in ischemic stroke
31. Role of Brain Liver X Receptor in Parkinson’s Disease: Hidden Treasure and Emerging Opportunities
32. Does vitamin D protect or treat Parkinson’s disease? A narrative review
33. Factors affecting the accumulation and variation of volatile and non-volatile constituents in rosemary, Rosmarinus officinalis L.
34. Hippo-YAP signaling and SARS-CoV-2 infection : a new mechanistic pathway
35. The potential role of cholesterol in Parkinson’s disease neuropathology: perpetrator or victim
36. Primary Hypothyroidism and Alzheimer’s Disease: A Tale of Two
37. Receptor-dependent effects of sphingosine-1-phosphate (S1P) in COVID-19: the black side of the moon
38. Fabrication, characterization and application of biocompatible nanocomposites: A review
39. Correction: Therapeutic potential of Lawsonia inermis Linn: a comprehensive overview
40. New insights on the potential effect of orexin receptor antagonist suvorexant on Parkinson’s disease symptoms
41. Correction to: The Possible Role of Brain-derived Neurotrophic Factor in Epilepsy
42. The potential effect of metformin on fibroblast growth factor 21 in type 2 diabetes mellitus (T2DM)
43. New insights on the potential effect of vinpocetine in Parkinson’s disease: one of the neglected warden and baffling topics
44. DPP-4 inhibitors and type 2 diabetes mellitus in Parkinson’s disease: a mutual relationship
45. Potential role of tirzepatide towards Covid-19 infection in diabetic patients: a perspective approach
46. The potential therapeutic effect of statins in multiple sclerosis: beneficial or detrimental effects
47. Parkinson’s Disease Risk and Hyperhomocysteinemia: The Possible Link
48. Pregnancy and COVID-19: high or low risk of vertical transmission
49. Pathogenic Role of Fibrinogen in the Neuropathology of Multiple Sclerosis: A Tale of Sorrows and Fears
50. Orexin pathway in Parkinson’s disease: a review
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.